duloxetine 40 MG Delayed Release Oral Capsule [Irenka]
RxNorm concept 1652069, branded drug (sbd). Prescribable name: Irenka 40 MG Delayed Release Oral Capsule.
- RxCUI
- 1652069
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1652069 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
DULoxetine 40 MG Delayed Release Oral Capsule [Irenka]; Irenka 40 MG (as DULoxetine hydrochloride 44.9 MG) Delayed Release Oral Capsule; Irenka 40 MG (as duloxetine hydrochloride 44.9 MG) Delayed Release Oral Capsule; Irenka 40 MG Delayed Release Oral Capsule
Related concepts
- duloxetine 40 MG (SCDC, consists of)
- duloxetine 40 MG [Irenka] (SBDC, consists of)
- Delayed Release Oral Capsule (DF, has dose form)
- Irenka (BN, has ingredient)
- duloxetine 40 MG Delayed Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
- 27437029806
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1652069 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1652069 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1652069. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.